PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D023F06098510100624!other medical — Pfizer Inc

Pfizer Inc holds $3.2B across 1,961 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 3 related awards under parent SPE2D020D0014. PoP ended Sep 30, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Pfizer Inc

Recipient

Sep 30, 2024

PoP end

$674K

Obligated

$731K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Pfizer Inc — $90

Contract facts

Federal

Contract numberSPE2D023F0609

Also listed asSPE2D0-23-F-0609

Also listed asSPE2D020D0014-SPE2D023F0609

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentPfizer Inc

CAGE86491

UEIMHBQULRMEEJ5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2D020D0014

Place of performanceNEW YORK NY

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startAug 24, 2023

PoP end (current)Sep 30, 2024

Obligated$674K

Current value$731K

Potential value$731K

8510100624!OTHER MEDICAL is a federal award for Dla Troop Support held by Pfizer Inc. Estimated value $731K ($674K obligated). Current period of performance ends Sep 30, 2024. Place of performance: NEW YORK NY.

Recompete timing

Public

● Past PoP end (690 days ago)

Current PoP ended Sep 30, 2024 (690 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Pfizer Inc — $3.2B obligated across 1,961 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.2B) · all agencies

Department of Health and Human Services (HHS)$3.3B · 103%Department of Defense (DOD)$3.1M · 0%Department of Veterans Affairs (VA)$458K · 0%

Related awards

Same parent · incumbent

75A50325F63003

STERILE WATER FOR INJECTION 20ML

$11.0M

Sep 18, 2026

SPE2D025F0634

8511599130!OTHER MEDICAL

$787K

Sep 30, 2026

75A50326F63004

STERILE WATER FOR INJECTION, 20ML

$10.4M

Sep 19, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2D023F0609?

SPE2D023F0609 (8510100624!other medical) is a Dla Troop Support award with a potential value of $731K, currently held by Pfizer Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2D0-23-F-0609?

SPE2D0-23-F-0609 is the dashed form of PIID SPE2D023F0609 (8510100624!other medical), held by Pfizer Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2D023F0609?

Dla Troop Support awarded SPE2D023F0609 to Pfizer Inc (potential $731K).

Who is the incumbent on SPE2D023F0609?

Pfizer Inc is the incumbent with $3.2B across 1961 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2024.

When does Pfizer Inc’s SPE2D023F0609 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 25, 2026 · refreshed monthlyLatest procurement action Apr 30, 2025